How to buy Dynavax Technologies Corporation stock (DVAX)

Dynavax Technologies Corporation is a drug manufacturers - specialty & generic business based in the US. Dynavax Technologies Corporation shares (DVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.72 – a decrease of 1.85% over the previous week. Dynavax Technologies Corporation employs 408 staff and has a trailing 12-month revenue of around $260.8 million.

Our top picks for where to buy Dynavax Technologies Corporation stock

Buy Dynavax Technologies Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Dynavax Technologies Corporation stock price (NASDAQ: DVAX)

Use our graph to track the performance of DVAX stocks over time.

Dynavax Technologies Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$12.72
52-week range	$9.74 - $15.01
50-day moving average more info button	$12.06
200-day moving average more info button	$11.60
Wall St. target price	$24.60
PE ratio more info button	85.1333
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.15

Is it a good time to buy Dynavax Technologies Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dynavax Technologies Corporation price performance over time

Historical closes compared with the close of $12.76 from 2024-12-19

1 week (2024-12-13)	-1.54%
1 month (2024-11-22)	2.74%
3 months (2024-09-20)	12.42%
6 months (2024-06-21)	11.64%

1 year (2023-12-22)	-7.80%
2 years (2022-12-22)	11.73%
3 years (2021-12-22)	14.04
5 years (2019-12-20)	88.20%

Is Dynavax Technologies Corporation stock undervalued or overvalued?

Valuing Dynavax Technologies Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dynavax Technologies Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Dynavax Technologies Corporation's P/E ratio

Dynavax Technologies Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 85x. In other words, Dynavax Technologies Corporation shares trade at around 85x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Dynavax Technologies Corporation financials

Revenue TTM	$260.8 million
Operating margin TTM	15.24%
Gross profit TTM	$448.2 million
Return on assets TTM	-0.38%
Return on equity TTM	3.18%
Profit margin	7.85%
Book value	$5.19
Market Capitalization more info button	$1.7 billion

TTM: trailing 12 months

Dynavax Technologies Corporation share dividends

We're not expecting Dynavax Technologies Corporation to pay a dividend over the next 12 months.

Have Dynavax Technologies Corporation's shares ever split?

Dynavax Technologies Corporation's shares were split on a 1:10 basis on 9 November 2014 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dynavax Technologies Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Dynavax Technologies Corporation shares which in turn could have impacted Dynavax Technologies Corporation's share price.

Dynavax Technologies Corporation share price volatility

Over the last 12 months, Dynavax Technologies Corporation's shares have ranged in value from as little as $9.74 up to $15.01. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dynavax Technologies Corporation's is 1.342. This would suggest that Dynavax Technologies Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Dynavax Technologies Corporation overview

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc. ; Clover Biopharmaceuticals (Hong Kong) Co. , Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt.

Frequently asked questions

null
What percentage of Dynavax Technologies Corporation is owned by insiders or institutions?
Currently 0.335% of Dynavax Technologies Corporation shares are held by insiders and 104.687% by institutions. How many people work for Dynavax Technologies Corporation?
Latest data suggests 408 work at Dynavax Technologies Corporation. When does the fiscal year end for Dynavax Technologies Corporation?
Dynavax Technologies Corporation's fiscal year ends in December. Where is Dynavax Technologies Corporation based?
Dynavax Technologies Corporation's address is: 2100 Powell Street, EmeryVille, CA, United States, 94608 What is Dynavax Technologies Corporation's ISIN number?
Dynavax Technologies Corporation's international securities identification number is: US2681582019 What is Dynavax Technologies Corporation's CUSIP number?
Dynavax Technologies Corporation's Committee on Uniform Securities Identification Procedures number is: 268158102